Intrust Bank Na Corcept Therapeutics Inc Transaction History

Intrust Bank Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$9.78 - $12.76 $99,756 - $130,152	-10,200 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$10.03 - $15.71 $136,177 - $213,294	-13,577 Reduced 57.1%	10,200 $120,000
Q4 2018 Feb 06, 2019	BUY	$11.29 - $17.19 $268,442 - $408,726	23,777 New	23,777 $318,000
Q3 2018 Nov 09, 2018	SELL	$12.27 - $15.65 $187,559 - $239,225	-15,286 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$15.3 - $19.69 $56,671 - $72,931	3,704 Added 31.98%	15,286 $240,000

Q1 2018 May 03, 2018	BUY	$14.59 - $25.5 $168,981 - $295,341	11,582 New	11,582 $191,000

316

93.8M

2.02M

3.24M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

Stay updated on Intrust Bank Na with notifications on news.